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We recently found that ATM is required for a selenium-induced senescence response 
in non-cancerous cells. We hypothesize the selenium-induced DNA damage response 
modifies ATM and DNA-PKcs cross-talk. Phospho-specific antibodies against ATM 
and DNA-PKcs were used to follow the phosphorylation events after selenium 
treatment in normal human cells and two human cancer cell lines. Results from 
immunofluorescence analysis showed that selenium treatment induces 
hyperphosphorylation of DNA-PKcs at T2647 and S2056 in non-cancerous MRC-5 
cells but not in U-2 OS cancer cells. Further studies in MRC-5 cells treated with an 
ATM kinase inhibitor, KU 55933, showed attenuation of the selenium-induced DNA-
PKcs phosphorylation at both foci, whereas pre-treatment with a DNA-PKcs kinase 
inhibitor, NU 7026, does not prevent ATM phosphorylation at S1981, an event 
leading to ATM pathway activation.  These results give evidence that DNA-PKcs and 
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Chapter 1: Literature Review 
1.1 Cancer Prevention, Cancer Incidence and Nutrient Intervention 
1.1.1 Cancer Prevention and Incidence 
Cancer prevention is a relatively young field.  Early studies of cancer 
prevention came from studies in pre-industrial Europe where chimney sweeps who 
worked naked, in order to avoid soiling their only set of clothes, were at greater risk 
of developing scrotal cancer than those who  swept in clothes (LaMontagne AD, 
2000).  English physician Percivall Pott recommended chimney sweeps work with 
their clothes on to decrease their chances of developing cancer; Dutch sweeps who 
followed his recommendation did in fact have a lower incidence of cancer.  These 
observational findings were later confirmed in animal studies, which showed 
absorption of polycyclic aromatic hydrocarbons from the soot were responsible for 
the cancer incidence (J Cook, 1933).  Fast forward two centuries to the 1980’s, and 
the molecular mechanisms of cancer promoting agents such as  benzo(a)pyrene and 
aflatoxins were first being elucidated in colon cancer models and other epithelial 
neoplastic lesions (Vogelstein et al., 1988).  In the decades since, in addition to 
increased elucidation of the molecular events leading to cancer, there has also been in 
increase in cancer prevalence, making it even more important to identify risk factors 
and discover possible novel cures. 
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Figure 1.1:  The History of Cancer Prevention 
 
1.1.2 Nutrient Intervention 
There have been incidences of nutrients and whole foods having a positive effect 
on the progression of tumorigenesis. Coumarins (Ito et al., 2005), garlic extracts 
(Nishino et al., 1989), green and black teas (Mehrabian, 2007), and resveratrol (Jang 
et al., 1997), have all been shown to have anti-carcinogenic effects.  Most of the 
nutrient chemoprevention studies have been done in cell or animal models, and not in 
large-scale human trials.  Although the data is promising, it wise to proceed with 
caution.  The best possible outcome of these studies would be application to humans 
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based on their specific genotypes.  The fields of nutrigenomics and personalized 
nutrition are gaining momentum quickly and are a promising approach for cancer 
prevention. 
In 1983 The U.S. National Cancer Institute (NCI) founded the Division of Cancer 
Prevention and Control (later the Division of Cancer Prevention) and conducted the 
first large clinical chemoprevention workshop in 1984. The capstone of these trials is 
the SELECT Selenium and Vitamin E [prostate] Cancer Prevention Trial which had 
negative-neutral results (Lippman et al., 2009).  The trial monitored over 35,000 men 
at 400 sites in the United States, Puerto Rico, and Canada taking oral selenium (200 
µg/d from L-selenomethionine) and Vitamin E daily.  It was found that selenium or 
vitamin E, alone or in combination, did not prevent prostate cancer in this population 
of relatively healthy men.  However, other studies have shown that selenium has a 
role in preventing cancer.   Many in the field of selenium chemoprevention point out 
weaknesses in the study such as; age of subjects, nutrient status, timing of data 
collection, and lack of immunohistochemistry or molecular techniques. 
 
1.1.3 Selenium as an Antioxidant 
Selenium is a micronutrient found in nuts, especially the Brazil nut, chicken, fish, 
turkey, crab, cereal and eggs.  The recommended daily allowance for males and 
females is 55 and 70 µg/day, respectively, as established by Food and Nutrition Board 
(FNB) of the Institute of Medicine. This RDA is based on the amount of dietary 
selenium needed to maximize the activity of glutathione peroxidase, an antioxidant 
enzyme in plasma (Monsen, 2000).  In 1997, Combs, Clark and colleagues showed a 
Caroline Rocourt Page 9 
 
role of selenium in cancer prevention (Combs et al., 1997).  Specifically they showed 
dietary intake of 200 µg of selenium enriched yeast reduced total mortality, mortality 
from all cancers, and decreased the incidence of lung cancer, colorectal cancer and 
prostate cancer.  This study tested the hypothesis that dietary selenium can prevent 
cancer primarily through its role as an antioxidant.  Selenium is an essential trace 
mineral and is well known for its antioxidant activity, primarily through its 
incorporation into selenoproteins such as glutathione peroxidase and thioredoxin 
reductase, which are important oxidative enzymes that are able to scavenge free 
radicals.   
By identifying a specific selenocysteine insertion RNA structures known as Sec 
insertion sequences (SECIS), Krukov and colleagues found there are 25 
selenoproteins in the mammalian genome (Kryukov et al., 2003).   Selenoproteins are 
also important in immune (McKenzie et al., 1998) and thyroid function, particularly 
its regulation of thyroid hormones (Arthur et al., 1992).  One of the earliest signs of 
selenium deficiency is immune deficiency, and interestingly, selenium and/or vitamin 
E deficiency in the host can increase RNA virus’ virulence, in particular 
coxsackievirus B3 (Levander, 1997). 
 
1.1.4 Selenium as an Inducer of a DNA Damage Response 
Selenium’s role in chemoprevention is not yet fully elucidated; however, there 
have been many proposed mechanisms of how selenium can decrease the risk of 
developing cancer such as: initiation or attenuation of apoptosis (Cho et al., 1999; 
Santamaria et al., 2005; Jariwalla et al., 2009; Zeng et al., 2009), decrease of 
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angiogenesis (McAuslan and Reilly, 1986; Jiang et al., 1999; Lu, 2001; Mousa et al., 
2007), induction of cell cycle arrest (Zu et al., 2006; Zeng et al., 2009; Zhao et al., 
2009) increase in DNA damage repair and response (Kaeck et al., 1997; Sinha et al., 
1999; Seo et al., 2002; Yin et al., 2004; Waters et al., 2005; Fischer et al., 2006; 
Traynor et al., 2006; Yu et al., 2006; Fischer et al., 2007), increased mitochondrial 
dysfunction and caspase activation (Guan et al., 2009), increased endoplasmic 
reticulum stress (Wu et al., 2005), increased activity of  tumor suppressor proteins 
(Berggren et al., 2009),  as an intracellular generator of ROS (Lanfear et al., 1994; Ip 
et al., 2000; Soto-Reyes et al., 2005; Last et al., 2006; Xu et al., 2007), initiation of a 
cytotoxic response (Reid et al., 2004; Olm et al., 2009), increase of cellular radio 
sensitivity (Shin et al., 2007)  and induction of cellular senescence (Cheng lab, 
unpublished.) 
To elaborate on the more well studied mechanisms of selenium chemoprevention, 
a collective body of research has demonstrated selenium as a powerful inducer of 
apoptosis, possibly  due to its cytotoxicty, which can activate a signaling pathway in 
the cell that ultimately can lead to apoptosis in cancer cells (Cho et al., 1999).  In a 
2004 study it was shown selenite treatment on U-2 OS cells actually decreased the 
cancer cell’s ability for DNA damage repair (Abul-Hassan et al., 2004). This 
inhibition of DNA damage in cancer cells could be beneficial because defective DNA 
damage repair might signal an apoptotic or senescence pathway in the cell; however, 
this study found selenite treatment increased the prevalence of dicentric 
chromosomes.  Antioxidants other than selenium, such as silibinin, extracted from 
milk thistle, can activate the DNA-PK-p53 pathway and induce apoptosis which 
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could also be another potential mechanism for selenium to therapeutically target 
cancer cells (Dhanalakshmi et al., 2005). 
     Apart from selenium’s potential to treat cancer, it has also been shown that 
selenium can prevent cancer.  Epidemiological studies have shown humans taking 
200 µg of selenium yeast have a decreased risk of cancer.  The epidemiological 
studies do not fully explain the mechanism of selenium chemoprevention.  We 
propose that a mechanism of selenium chemoprevention is its ability to activate early 
tumorgenesis barriers such as senescence and DNA damage response.  Before 
genomic instability and malignant conversion, normal cells undergo activation of 
DNA damage response (Bartkova et al., 2005), which is a proposed tumor barrier.  It 
is thought that cells in this state could potentially never progress to cancer, if the 
proper signaling pathways remain intact. It is hypothesized selenium’s metabolites 
can induce a ROS response.  This ROS response could activate certain signal 
transduction pathways that would lead to an increased DNA damage response, thus 
preventing the cells from further tumorgenesis.  In this study we examine a novel role 
of selenium as an inducer of DNA damage response and show that selenium can up-
regulate genes involved in the DNA double strand break (DSB) response, thus 
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1.2 The DNA Double Strand Break Response  
1.2.1 The PI3K-like protein kinases  
       DNA double strand breaks promote cell death or genomic instability. DSBs are a 
dangerous type of DNA damage that can occur within the cell.  A family of proteins, 
phosphoinositide-3-kinase-related protein kinases (PIKK) are activated in response to 
DNA damage, in particular, two of three are activated in response to DSBs.  Three 
important members of this family are Ataxia telangiectasia mutated (ATM), ataxia 
telangiectasia and Rad3-related (ATR) and DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs). ATR is activated in response to single-stranded DNA and 
stalled  replication forks while ATM and DNA-PKcs respond to DSBs (Falck et al., 
2005).   DNA damage, and DSBs breaks in particular, can be induced by exogenous 
and endogenous sources.  An exogenous source of DNA damage would be ionizing 
radiation and an endogenous example would be innate cellular metabolism, which 
generates reactive oxygen species (ROS); both types of DNA damage have been 
known to cause DSBs (Khanna and Jackson, 2001).  After a double strand break is 
formed, the cell responds by activating sensor proteins, which recognize the damage, 
then activate transducer proteins that relay and amplify the damage signal.  Finally 
effector proteins are activated, which can modulate the cell cycle, reconstruct 
chromatin, and control DNA repair (See Figure 1.2).   
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Figure 1.2 The DNA Double Strand Break Response. 
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1.2.3 Double Strand Break Signaling: ATM  
        The ataxia telangiectasia mutated protein is mutated in the genetic disorder 
ataxia telangiectasia.  Patients suffering from this disease exhibit ataxia, immune 
defects, and cancer predisposition (Chan et al., 2000). ATM is a transducer protein.  
When ATM is activated in response to DSBs, it can promote cell cycle checkpoint 
arrest and allow the cell time for repair.  It was shown in 2001 ATM is the major 
kinase involved in the phosphorylating histone 2A (H2A). They specifically found 
ATM can phosphorylate H2A in vitro and that ectopic expression of ATM in ATM
−/−
 
fibroblasts restores H2A phosphorylation in vivo. This suggests ATM is one of the 
first proteins to be activated by DNA damage (See Figure 1.3) and one of the initial 
proteins to respond to DSBs (Burma et al., 2001). Molecular characteristics of ATM 
deficiency include delayed up-regulation of p53 in response to ionizing radiation. 
Substrates of ATM include Chk2, PHAS-I, the 32-kDa subunit of RPA and serine 15 
of p53 in vitro; all of these sites are dependent on manganese concentration.   In each 
case, phosphorylation was strictly dependent on manganese, and might be a common 
characteristic  for all PIKK kinases (Chan et al., 2000).  
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Figure 1.3 Activation of ATM.  ATM is a master protein involved in the signal 
transduction pathway of the DNA double strand break response.  It is recruited to site 
of DNA damage, in a conserved manner, similar to ATR and DNA-PKcs, other PIKK 
proteins, by smaller effectors proteins (Falck et al., 2005).  This recruitment is 
facilitated by evolutionary conserved motifs in the effector proteins: Ku for DNA-
PKcs, ATRIP for ATR, and the MRN complex for ATM.  These proper signaling 
pathways are necessary for the fidelity of the DNA double strand break response. 
  
1.2.3 Double Strand Break Repair: DNA-PKcs and NHEJ 
         In mammalian cells, the non-homologous end-joining (NHEJ) is the main 
pathway that repairs DNA double strand breaks.  The proteins Ku70, Ku80 and DNA-
PKcs together form the holoenzyme DNA-dependent protein kinase (DNA-PK) which 
is activated in the presence of DNA in vitro and is required for proper NHEJ function 
(Chan et al., 2002). The NHEJ pathway is the  predominate pathway that repairs 
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DNA double strand breaks in all stages of the cell cycle (Mao et al., 2008). 
 
Figure 1.4 Simplified Mechanism of the Non-Homologous End-Joining pathway   
This pathway, in contrast to the homologous recombination, is error prone because it 
does not invade a sister chromatid and gather the correct bases.  Homologous 
recombination only takes place when there is a homologous template available, such 
as during S-phase.  Although, the NHEJ pathway simply ligates the double strand 
break with minimal processing, it is actually the main pathway in the mammalian cell 
for repairing DNA double strand breaks (Mao et al., 2008). 
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            DNA-PKcs is the 460 kDa catalytic subunit associated with this pathway (See 
Figure 1.4 for more details).  Unpublished research from our lab shows the 
responsibility of phosphorylating histone H2A.X at serine 139, surrounding regions 
of DNA damage, could be shared between ATM and DNA-PKcs.   The catalytic 
subunit DNA-PKcs is rapidly phosphorylated at the Thr-2609 cluster and Ser-2056 
upon ionizing radiation (IR).  The threonine 2609 cluster includes the threonine 2647 
site, and is phosphorylated in vivo in an ATM-dependent manner in response to 
DSBs, particularly after IR (Chen et al., 2007).  The serine 2056 residue is 
autophosphorylated in response to DNA damage (Chan and LeesMiller, 1996), and its 
phosphorylation is required for the repair of DSBs by NHEJ (Chen et al., 2005). IR-
induced DNA-PKcs autophosphorylation is cell cycle dependent; there is less auto-
phosphorylation of DNA-PKcs in the S-phase (Chen et al., 2005). Interestingly, 
phosphorylated DNA-PKcs colocalizes with both γH2A.X and 53BP1 after DNA 
damage, demonstrating that DNA-PKcs is present at sites of DNA damage (Chan et 
al., 2002). 
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Figure 1.5 Major Features of DNA-PKcs.  The major of DNA-PKcs are highlighted 
above, and many of the regions such as the FAT, PIKK, and HEAT repeats are 
evolutionary conserved across other members of the PIKK family, such as ATM and 
ATR.  DNA-PKcs is rapidly phosphorylated in vivo in response to DNA damage.  
There are many DNA-PKcs phosphorylation sites, however, for the purpose of this 
work, threonine 2647, phosphorylated in response to ATR and ATM kinase activity 
and serine 2056, an autocatalytic phosphorylation site, are of particular interest. 
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1.2.4 Cross-talk between the proteins  
It has been shown ATM is not fully responsible for decreased radio sensitivity 
in human malignant glioma cell lines (Chan et al., 1998) and when ATM kinase 
activity is inhibited in normal MRC-5 cells, the phosphorylation of histone 2A is only 
partially inhibited (Cheng, unpublished data).  Also, it was shown in the Cheng lab 
that ATM is required for a selenium-induced senescence response.  Therefore, this 
data led us to hypothesize that another protein, possibly a PIKK family member, is 
responsible for a normal radiosensitivity response, phosphorylation of histone sensing 
marker, H2A, and a normal selenium-induced senescence response.  This protein 
could be DNA-PKcs; its levels throughout the cell cycle are mostly consistent (see Fig 
1.6), and its proper function is necessary for the correct repair of DNA double strand 
breaks.  For this reason, we are interested in studying the cross-talk between PIKK 
family because this interaction could be crucial for proper DNA response and repair. 
 
1.3 Hypothesis and concept  
In the broad field of chemoprevention, selenium has not yet been selected as a 
prime target for induction of DNA damage repair. We hypothesize the 
chemopreventive properties of selenium are due to activation of early tumorigenesis 
barriers, such as induction of DNA damage response and senescence.    We show here 
that selenium induces a DNA damage response in normal MRC-5 cells, but not in two 
cancer cell lines.  
  
 
Caroline Rocourt Page 20 
 
 
Chapter 2: Materials and  Methods 
 
2.1 Cell Culture and Drug Treatments 
The non-cancerous MRC-5 human lung fibroblasts were cultured in α-minimum 
Eagle's medium supplemented with 15% fetal calf serum, 1% essential amino acids, 
1% non essential amino acids, 1% vitamins, 0.5% amphotericin B, 1% penicillin-
streptomycin and 5 μg/ml plasmocin (Invitrogen, Carlsbad, California). The 
generation of ATM short-hairpin RNA (shRNA) and control cells using the U-2 OS 
osteosarcoma cell line have been described previously (Cheng et al., 2008).  ATM 
shRNA U-2 OS and U-2 OS control cells were maintained in Dulbecco's Modified 
Eagle Medium supplemented with 10% fetal calf serum, 0.5% amphotericin B, 1% 
penicillin-streptomycin and 5 μg/ml Plasmocin (Invitrogen). For immunofluorescence 
assays, exponentially growing cells grown on coverslips in 6-well plates were treated 
with a combination of the following chemicals; 1 or 2 μM of sodium selenite 
(Sigma,St. Louis, Missouri) for 24 h, 100, 300, or 500 μg/ml of neocarzinostatin 
(Sigma) for 10 min, 50 μM NU 7026 for 24 h (Tocris, Ellisville, Missouri), 10 μM 
KU 55933 (Tocris), for 24 h, and 1 μg/mL aphidicolin (Tocris), for 24 h at the 
indicated concentrations at 37 °C. 
 
2.2 Colony Formation  
h-TERT immortalized mouse embryonic fibroblasts harboring deficiencies in the 
proteins making up the non-homologous end-joining pathway were grown to 80% 
confluency then seeded (10,000 for wild type mouse embryonic fibroblasts and 5,000 








) into 6-cm dishes with 2 mL DMEM and 
incubated for two weeks in either 20% oxygen or 3% oxygen.  In addition to the 
media 0, 1, 2, 5 µM Sodium Selenite, 0, 1, 2, 5, 10 µM Methaneseleninic acid, 95% 
and 0, 10, 20, 50, 100 µM Se-Methyl-selno-L-cysteine were added to the media.  
Media was changed one week after seeding.  After two weeks, cells were fixed with 
methanol, stained with Coomassie blue dye and counted.  Analysis was done by 
counting the number of colonies, then determining the percentage they represent of 
the control (percent of 100).  Multiple independent experiments were done to 
generate error bars. 
 
2.3 Detection of Reactive Oxygen Species (ROS) 
Intracellular ROS were detected using 5-(and-6)-chloromethyl-2',7'-
dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA) (Invitrogen). 
DCFDA is a permanent indicator of ROS that is nonfluorescent until removal. The 
acetate groups are removed by intracellular esterases causing oxidation within the 
cell.  Mouse embryonic fibroblasts and the corresponding NHEJ mutants were treated 
with 0, 1, 2, 5 µM Sodium Selenite, 0, 1, 2, 5, 10 µM Methaneseleninic acid, 95% 
and 0, 10, 20, 50, 100 µM Se-Methyl-selno-L-cysteine for 24 hours, then rinsed with 
PBS. They were then incubated with 10 uM DCFH-DA for 30 min at 37 °C.Lastly the 
cellular fluorescence intensity was detected using a fluorescence microplate reader 
(FLUOstar OPTIMA, BMG LABTECH, Cary, North Carolina) and a fluorescent 
microscope (Zeiss, Thornwood, New York).  
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2.4 Immunofluorescence and Antibodies 
phospho-DNA-PKcs T2647 (lot 903801) and phospho-DNA-PKcs S2056 (lot 696143) 
polyclonal antibodies were purchased from Abcam (Boston, Massachusetts).  Total 
DNA-PKcs and anti-γH2AX S139 (lot 41665603) monoclonal antibodies were also 
purchased from Abcam. Total ATM antibody (lot YF-10-17-02) was purchased from 
Epitomics (Burlingame, California) and phospho-ATMS1981 (lot 20772) antibody 
was purchased from Rockland (Gilbertsville, Pennsylvania).  MRC-5, ATM shRNA, 
and control shRNA cells were grown on slides to about 70% confluence and then 
treated with the chemicals described above. Cells were fixed in 4% paraformaldehyde 
for 15 min, permeabilized with ice cold methanol for 10 min at – 20° C, 
permeabilized again for 10 min in 0.3% Triton X-100, and blocked in 10% normal 
goat serum / 0.3 M glycine in phosphate buffered saline (PBS) for 1 h to permeabilize 
the cells and block non-specific protein-protein interactions. The slides were 
incubated with the described antibodies overnight, washed in PBS, and incubated 
with Alexa Fluor 488-conjugated goat anti-rabbit and Alexa Fluor 594-conjugated 
goat anti-mouse secondary antibodies (Invitrogen) for 1 h at room temperature. Cells 
were then washed in PBS and mounted onto slides containing a drop of 4,6-
Diamidino-2-phenylindole (DAPI) (Invitrogen) that stains the nuclei. The 
immunostaining was visualized by a Zeiss Axio Observer Z1m (Zeiss) and images 
were processed using deconvolution with the software AxioVision. To allow direct 
comparisons, all the cells were irradiated and processed simultaneously and all the 
images were obtained using the same parameters (brightness, contrast, etc.).  
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2.5 Quantification and Statistics of Immunofluorescence Data 
An image was taken of each cover slip (one treatment) three times at 20x, then the 
nuclei were outlined using the spline function.  The properties were measured and the 
mean densometric intensity was measured for each channel.  The intensities for each 
nucleus were averaged over the samples and the phospho mean densometric intensity 
was divided by the nuclei mean densometric intensity, multiplied by a hundred to 
determine the intensity as a percent of the control.  These numbers were averaged and 
then plotted on a graph. Multiple student’s t-tests were done to analyze the means of 
various treatments.  
 
2.6 Chemicals and Reagents 
All chemicals and reagents (Appendix I), buffers (Appendix II), and commercial kits 
(Appendix III) can be found in the appropriate appendices. 
 
2.7 Equipments and facilities used  
All equipments and facilities were provided by Department of Nutrition and Food 
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Chapter 3: Results  
3.1 Colony formation assay 
20% Oxygen MEF Survivability































3% Oxygen MEF Survivability
































Figure 3.1 MEFs treated with Sodium Selenite Survival Data.  The graph displays 
cell survivability of mouse embryonic fibroblasts treated with sodium selenite after a 
two week incubation in 20% and 3% oxygen. (20% oxygen: n=3; two way ANOVA 
p=0.99; bonferonni post tests showed no significance of mutants compared to wild 
types; 3% oxygen: n=3; two way ANOVA p=0.72; bonferonni post tests showed no 
significance of mutants compared to wild types. In both graphs, error bars are 
standard error of mean.)  
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Figure 3.2 MEFs treated with Methaneseleneninic Acid, 95% Survival Data.  
The graph displays cell survivability of mouse embryonic fibroblasts treated with 
methaneseleninic acid, 95% after a two week incubation in 20% and 3% oxygen. 
(20% oxygen: n=3, two way ANOVA p=0.1326; bonferonni post tests=  Ku70
-/-
  
treated with 2 μM methaneseleninic acid and DNA-PKcs
-/-
 treated with 1, 2,5, and 10 
μM methaneseleninic acid are significantly different from the wild type control;  3% 
oxygen: n=3, two way ANOVA  p=0.9740;  bonferonni post tests showed no 
significance of mutants compared to wild types.  In both graphs, error bars are 
standard error of mean.) 
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Figure 3.3 MEFs treated with Se-Methyl-selno-L-cysteine Survival Data.  The 
graph displays cell survivability of mouse embryonic fibroblasts treated with Se-
Methyl-selno-L-cysteine after a two week incubation in 20% and 3% oxygen. (20% 
oxygen: n=3; two way ANOVA p=0.754; bonferonni post tests showed no 
significance of mutants compared to wild types; 3% oxygen: n=3; two way ANOVA 
p=0.99; bonferonni post tests showed no significance of mutants compared to wild 
types.  In both graphs, error bars are standard error of mean.) 
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After treatment of selenium to all cell lines, they were incubated for two 
weeks in either 20 %  oxygen, normal cell culture conditions, or 3%  oxygen, which 
is similar to in vivo oxygen concentrations (Li et al., 2009).  The lower percentage of 
oxygen has been shown to generate less oxidative stress, which is favorable to extend 
the lifespan of cells cultured in vitro (Parrinello et al., 2003).  Across all three types 
of selenium treatment (See Figures 3.1- 3.3), cells appear to be able to tolerate a 
greater dose of selenium when incubated in 3% oxygen.  The cells with the highest 
survivability on average were the mouse embryonic fibroblasts deficient in DNA-
PKcs.  However, it should be mentioned the mutant cells are immortalized with h-
TERT, which can extend their replicative potential, and this could be a reason why 
there is little statistical significance when comparing the wild type survivability to the 
mutant survivability.  If this experiment was repeated using primary cells with the 
core protein components of the NHEJ pathway knocked out, it is uncertain whether 
primary cells would have similar survivability responses to selenium treatment.   
Figure 3.1 illustrates how sodium selenite affects survivability in mouse 
embryonic fibroblasts.  Interestingly, the survivability of MEFs incubated with 
sodium selenite can be explained as function of ROS; decreased survivability of the 
wild type cells in 20% percent oxygen can be explained by their higher levels of  
ROS and the increased survivability of the mutants in 20% can be explained by their 
lower concentrations of ROS (see Figure 3.4). Another interesting trend see in cells 
incubated in physiological oxygen conditions (3%), and treated with sodium selenite, 
is the mutant cells offer protection against selenite induced cell death, presumably 
due to their decreased ROS response. 
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The highest dose of methaneseleninic acid, 20 µM, could be on the verge of 
toxic because no cell type thrived in this environment.  For the Se-Methyl-selno-L-
cysteine the highest dose chosen was conservative compared to highest dose chosen 
for sodium selenite and the acid. Se-Methyl-selno-L-cysteine is an organic form of 
selenium, and might explain why the highest dose is much less toxic than a lower 
dose of the inorganic selenium.  Organic selenium is better tolerated in vivo because it 
is thought to be not as toxic as inorganic selenium.  Furthermore, the selenium found 
in supplements and in whole foods is in the organic form, often complexed with 
yeast. 
Although the results are slightly different for each type of selenium, it can be 
postulated Ku80, a protein that binds to DNA damage and recruits DNA-PKcs 
(Spagnolo et al., 2006),  is the most necessary of these three NHEJ proteins to combat 
ROS induced oxidative stress.  When Ku80 mutant cells are challenged with 
increasing doses of different types of selenium, the Ku80 mutant cells are the most 
sensitive to selenium treatment and least likely to thrive.  This is interesting because 
in mice models, the effect of Ku80 deletion is a much more severe phenotype then 
Ku70 deletion (Li et al., 2007; Li et al., 2009).  To further understand why the protein 
components of the NHEJ pathway affect the lifespan of fibroblasts challenged with 
selenium, intracellular ROS was measured.  Here we tested the hypothesis that 
selenium, in supranutritional doses, can generate ROS through its own metabolism. 
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3.2 Detection of ROS 
Figure 3.4 Reactive Oxygen Species in Mouse Embryonic Fibroblasts. Mouse 
embryonic fibroblasts with non-homologous end-joining components knocked down, 
treated with selenium for 24 h in 20% oxygen then measured for ROS using a 
fluorescent plate reader.  Results were confirmed with a fluorescent microscope.  
Also shown is wild type mouse embryonic fibroblasts treated with a chemical DNA-
PKcs inhibitor, NU 7026 then measured for ROS production. The error bars represent 


























































Types and Concentrations of Selenium
ROS Activity in Mouse Embroynic Fibroblasts 
MEF WT 33s 50 μM Nu7026 + Se treatment MEF WT 33s Se treatment
MEF DNA-PKcs-/- Se treatment MEF Ku70-/- Se treatment
MEF Ku80-/- Se treatment




ROS production, the generation of free radicals containing an oxygen atom, 
were measured in mouse embryonic fibroblasts (MEFs) containing knockdowns of 
the important protein components of the non-homologous end-joining pathway.  The  







.  The cells were obtained already knocked 
down and all cell types were subjected to inorgranic (sodium selenite) and organic 
selenium (Methaneseleninic acid, 95% and Se-Methyl-seleno-L-cysteine) then 
measured for ROS using a plate reading and fluorescent microscopy.  The results of 
the ROS assay showed in order for a selenium-induced ROS response, the protein 
components of the NHEJ had to be present.  This is a reasonable conclusion from the 







( See Figure 3.4).  
.
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Figure 3.5 Chemical Structure of NU 7026 (2-(4-Morpholinyl)-4H-naphthol[1,2-
b]pyran-4-one), an ATP-competitive inhibitor of DNA-dependent protein kinase that 
displays selectivity over other PIKK family enzymes. 
 
 
To test the validity of the of the ROS results in the cells lacking protein 
components of the NHEJ pathway, in particular the activity of  DNA-PKcs, a 
chemical inhibitor of DNA-PKcs was used to elucidate further the role of selenium in 
inducing a ROS response.  The wild type fibroblasts, which showed significantly 
higher levels of ROS after selenium treatment, were pretreated with 50 µM Nu 7026, 
a chemical DNA-PKcs inhibitor, followed by selenium treatment.  Results showed 
treatment with the chemical decreased the production of ROS significantly, similar to 
the effect of the DNA-PKcs knockdown fibroblast (See Figure 3.6). 
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Figure 3.6 Effect of DNA-PKcs inhibitor on ROS levels. Close up of mouse 
embryonic fibroblasts without DNA-PKcs treated with selenium versus mouse 
embryonic fibroblasts with DNA-PKcs treated with 50 µM NU 7026 followed by 
selenium treatment. WT 33s is included as the control (n=3; repeated measures 
ANOVA p for SSe=0.4002; p for MSA=0.0046; p for SeC=0.0187.)  In each graph, 
the error bars represent standard error of the mean. 
 
 
Figure 3.6 illustrates the effects of a DNA-PKcs inhibitor on two types of cells.  
In wild type cells treated with selenium, as seen in Figure 3.5, and again in Figure 
3.6, the percentage increase of ROS is significantly larger (200-600% percent) in wild 


























Reactive Oxygen Species Activity in MEFs 20% Oxygen
WT 33s WT 33s + 50 μM Nu7026 DNA-PKcs-/-
P=0.4002 P=0.0046** P=0.0187*
MSA, 95% (μM) SeC (µM) SSe (μM) 
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fibroblasts treated with NU 7026, or DNA-PKcs knockout fibroblasts. However, 
treatment with a DNA-PKcs inhibitor considerably decreases the selenium-induced 
ROS expression.  Comparing the two dashed lines in figure 3.6, there is a decreased 
ROS response in wild type fibroblasts treated with the chemical DNA-PKcs inhibitor, 
NU 7026.   Therefore, the inhibitor is successful in mimicking the ROS response seen 
in the fibroblasts with the DNA-PKcs gene knocked out.   
With SeC treatment (See Figure 3.6), the trends and the error bars overlap, 
possibly because the dose chosen was too conservative to illicit a ROS response; SeC 
is an organic form of selenium, the salt, with the highest ROS response, is inorganic.  
In order to see a similar ROS response in MEFs treated with the SeC form of 
selenium, higher concentrations maybe needed.  The necessity of the protein 
components of the NHEJ pathway to illicit a ROS response lead to the next 
experiment which established that mechanism responsible for the selenium-induced 
ROS response was the phosphorylation events surrounding the activation of DNA-
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3.3 Immunofluorescene   
3.3.1 MRC-5 Cells 
Figure 3.8 shows MRC-5 cells treated with or without 10 µM KU 55933 for 
24 h, an ATM inhibitor, and selenium for 24 h then probed for pDNA-PKcs S2056, 
pDNA-PKcs T2647 and γH2A.X.  Phosphorylation of DNA-PKcs is decreased when 
KU 55933, an ATM inhibitor was present. ATM kinase inhibition results in decreased 
inhibition of phosphorylation of DNA-PKcs at sernine 2056 and threonine 2647, 
although there is greater decrease in serine phosphorylation following selenium 
treatment.  Pretreatment with the inhibitor, but not selenium treatment, had the 
highest percentage of DNA-PKcs phosphorylation at serine 2056.  However, 
percentage of phosphorylation of threonine 2647 was highest when with no selenium 
or ATM inhibitor treatment. The trends are similar for MRC-5 cells pretreated with 
Aph for 24 h; except for threonine 2647 phosphorylation continues to decrease with 
increasing doses of selenium (See Figure 3.9). 
 
Figure 3.7: The structure of KU 55933 2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-
pyran-4-one, a potent, selective and competitive ATM kinase inhibitor.  
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Figure 3.8: Selenite induces DNA-PKcs phosphorylation at Threonine 2647 at the 
sites of DNA damage and this trend is decreased with ATM inhibition.  MRC-5 
cells treated with sodium selenite increases the phosphorylation of DNA-PKcs at 
T2647.  MRC-5 cells treated with 10 µM KU 55933 for 24 h, an ATM inhibitor, and 
selenium for 24 h show decreased T2647 phosphorylation.  A student’s t-test was 
done (p < 0.05, n=3) that showed there is statistical significance between 
phosphorylation of T2647 with or without KU 55933 at 0, 1, and 2 µM sodium 
selenite concentrations.  The error bars on the graph represent the standard error of 
the mean. 




 Figure 3.9: Selenite induces DNA-PKcs phosphorylation at Serine 2056 at the 
sites of DNA damage and this trend is decreased with ATM inhibition.  MRC-5 
cells treated with 10 µM KU 55933 for 24 h, an ATM inhibitor, and selenium for 24 h 
show decreased S2056 phosphorylation compared to cells treated with only selenium.  
A student’s t-test was done (p<.0.05, n=3) that showed there is statistical significance 
between phosphorylation of S2056 with or without KU 55933 at 0, 1, and 2 µM 
sodium selenite concentrations.  The error bars on the graph represent the standard 
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Figure 3.10: Chemical Structure of Aphidicolin Aphidicolin is an antibiotic that 
inhibits DNA polymerase α, stalling cells in the S-phase (See Figure 4.1). 
 
Sodium selenite significantly enhances phosphorylation of S2056 and T2647 
of DNA-PKcs at sites of DNA damage, as measured by H2A phosphroylation. The 
cells treated with Aph, synchronized in S-phase, particularly the S2056 residue of 
DNA-PKcs, show a decreasing phosphorylation (See Figure 3.11). Cells with no 
selenium treatment, but synchronized with Aph, show only partial phosphorylation at 
serine 2056 and not all cells in the field of view are phosphorylated when observing 
under a fluorescent microscope. However, with Aph synchronization and selenium 
treatment, there is greater phosphorylation and by using a fluorescent microscope it is 
clear most cells in the field of view are phosphorylated.   
 Treatment of synchronized MRC-5 cells can induce phosphorylation of 
DNA-PKcs at threonine 2647, without concurrent phosphorylation of H2A. After 
fluorescent observation and statistical quantification, Aph synchronized MRC-5 cells 
without selenium treatment show complete overlap in DNA-PKcs threonine 2647 
phosphorylation and H2A phosphorylation in all cells in the treatment.  
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There is statistical significance between the phosphorylation intensity of 
threonine 2647 and serine 2056 of DNA-PKcs in selenite treated MRC-5 cells 
depending whether they are in the S-phase.  For both foci, there is a decrease in the 
phosphorylation at both DNA-PKcs foci after synchronization in the S-phase. 
 
 
Figure 3.11 A: Selenite induces DNA-PKcs phosphorylation at Serine 2056 at 
sites of DNA breaks in the S-phase. Cells were synchronized in the S-phase with 
aphidicolin.  The total levels of DNA-PKcs are the same in each treatment (data not 
shown). A student’s t-test was done (p < 0.05, n=3) that showed there is statistical 
significance between phosphorylation of S2056 with or without Aph at 1 and 2 µM 
sodium selenite concentration.  The error bars on the graph represent the standard 
error of the mean. 
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Figure 3.11 B: Selenite induces DNA-PKcs phosphorylation at Threonine 2647 at 
sites of DNA breaks in the S-phase. Cells synchronized in the S-phase with 
aphidicolin.  The total levels of DNA-PKcs are the same in each treatment (data not 
shown). A student’s t-test was done (p< 0.05, n=3) that showed there is statistical 
significance between phosphorylation of T2647 with or without Aph at 1 and 2 µM 
sodium selenite concentration.  The error bars on the graph represent the standard 
error of the mean. 
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Figure 3.11 C: Selenite induces DNA-PKcs phosphorylation at Serine 2056 and 
Threonine 2647 at sites of DNA breaks in the S-phase. MRC-5 cells treated with 
Aph to arrest cells in the S-phase followed by selenium treatment then probed for 
pDNA-PKcs S2056, pDNA-PKcs T2647 and γH2A.X. Selenium treatment can induce 
phosphorylation of DNA-PKcs at serine 2056 and threonine 2647. 
γH2A.X 
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Figure 3.12: Neocarzstatin treatment effect on DNA-PKcs phosphorylation. 
MRC-5 Cells treated with Neocarzstatin then probed for pDNA-PKcs S2056, pDNA-
PKcs T2647, γH2A.X, and Total DNA-PKcs (not shown).  Total levels of DNA-PKcs 
were the same in each treatment.  A student’s t-test was done (p < 0.05, n=3) that 
showed there is statistical significance between phosphorylation of S2056 with NCS 
treatment and without.  These results show a similar phosphorylation pattern to 
selenium treatment. 
 
Normal MRC-5 cells are vulnerable to Neocarzstatin treatment in a dose 
dependent manner.  However, higher doses of Neocarzstatin cause cell death, and 
therefore less DNA-PKcs phosphorylation. 
* 
Caroline Rocourt Page 42 
 
 
Figure 3.13 A: DNA-PKcs inhibition effects on ATM phosphorylation. MRC-5 
cells treated with 50 µM NU 7026, a chemical DNA-PKcs inhibitor, and selenium 
then probed for total ATM and pATMS1981.  





Figure 3.13 B: DNA-PKcs inhibition effects on ATM phosphorylation in the S-
phase.  MRC-5 cells treated with Aph, 50 µM NU 7026, a chemical DNA-PKcs 
inhibitor, and selenium then probed for total ATM and pATMS1981.   
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Figure 3.14: Effect of ATM phosphorylation in NU 7026 treated MRC-5 cells.  
Sodium selenite can induce the phosphorylation of ATM at serine 1981 independent 
of DNA-PKcs kinase ability.  A student’s t-test was done (p<.0.05, n=3) that showed 
there is statistical significance between phosphorylation of S1981 of ATM with or 
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The total amount of ATM present in MRC-5 cells is independent of selenium 
and NU 7026 treatment. Measuring the total amount of protein was done in all 
experiments as a control regardless of protein type.  The purpose is to show the 
differences in phosphorylation levels were not due to a difference in total protein 
concentration.   As shown above, selenium treatment can induce phosphorylation of 
ATM at serine 1981, signaling its activation.  The phosphorylation of ATM is due to 
selenium treatment, not due to total amount of ATM present.    
The levels of total ATM are not dependent on selenium treatment; however 
selenium treatment induces phosphorylation in cells arrested in S-phase in cells 
treated with NU 7026.  With no selenium treatment, only one cell in the field of view 
has phosphorylated ATM, while selenium treatment increases the number of cells in 
each field of view with ATM phosphorylation.  Interestingly, ATM can be 
phosphorylated, signaling its activity, in the absence of DNA-PKcs kinase activity.  
ATM phosphorylation at serine 1981 in cells pretreated with NU 7026 is an upstream 
event independent of DNA-PKcs kinase activity.  




Figure 3.15: Effect of DNA-PKcs inhibition on MRC-5 Cells. A) MRC-5 cells 
treated with 50 µM NU 7026, a chemical DNA-PKcs inhibitor, and selenium then 
probed for pDNA-PKcs S2056, pDNA-PKcs T2647 and pATMS1981.   
     pS2056 
 
     pT2647 
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Figure 3.15: Effect of DNA- PKcs inhibition on MRC-5 Cells. B) MRC-5 cells 
treated with Aph, 50 µM NU 7026, a chemical DNA-PKcs inhibitor, and selenium 
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Enzymatic inhibition of DNA-PKcs decreases DNA-PKcs autophosphorylation 
at serine 2056 and ATM autophosphorylation at serine 1981.  Selenium treatment 
does induce slight phosphorylation of serine 2056 in DNA-PKcs and of serine 1981 in 
ATM in MRC-5 cells treated with NU 7026.  Using the same parameters but probing 
for DNA-PKcs pT2647, selenium can induce phosphorylation of threonine 2647, most 
likely through an ATM dependent pathway.   
In the synchronized experiment, enzymatic inhibition of DNA-PKcs, decreases 
DNA-PKcs autophosphorylation at serine 2056.  ATM/ATR dependent 
phosphorylation of DNA-PKcs at T2647 is eliminated after synchronization with Aph 
and treatment of NU 7026 and cannot be induced with selenium treatment unlike the 
unsynchronized experiment.  Treatment of MRC-5 cells with NU 7026 and 
synchronized with Aph does not activate ATM, however, treatment of selenium can 
induce activation of ATM, determined by the phosphorylation of ATM at serine 
1981. 
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3.3.2 ATM shRNA U-2 OS Cells  
 
 
Figure 3.16 ATM shRNA U-2 OS cells treated with sodium selenite. A) Probed 
for pDNA-PKcs S2056, pDNA-PKcs T2647 and γH2A.X. There is a DNA damage 
response, as evidenced by H2A phosphorylation, however with these doses of 
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Figure 3.16 B) ATM shRNA U-2 OS treated with selenium then probed for pDNA-
PKcs S2056, pDNA-PKcs T2647 and total DNA-PKcs. The total level of DNA is 
consistent throughout the samples; however there is no phosphorylation of DNA-PKcs 
at either foci. 
     pS2056 
     pT2647 
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Figure 3.16 C) ATM shRNA U-2 OS cells treated with NCS then probed for pDNA-
PKcs S2056, pDNA-PKcs T2647 and total DNA-PKcs.  There is DNA-PKcs is 
presenting in each sample, although NCS cannot induce significant phosphorylation 
of DNA-PKcs at either foci, unlike its effect on normal MRC-5 cells. 
     pS2056 
     pT2647 
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Unlike normal MRC-5 cells, there is no selenium-induced phosphorylation of 
DNA-PKcs at serine 2056 or threonine 2647 in cancer cells with ATM knocked down. 
γH2A.X signal is consistent in each treatment; it is not dependent on selenium 
treatment.  Also, γH2A.X signal is present even with ATM knocked down, showing 
that another protein must be share the responsibility of phosphorylating H2A.  
Unlike normal cells, there is no DNA-PKcs phosphorylation of DNA-PKcs at either 
serine 2056 or threonine 2647 under any treatment condition or in the control.   
The NCS expression in shRNA U-2 OS is faint; however the response may 
increase if the concentration of NCS was increased.  For cancer cells, the dose is most 
likely higher because normal cells are more vulnerable to chemical treatment. The 
total level of DNA-PKcs expressed the same in every condition, with each cell having 
similar amounts expressed.  Like ATM shRNA U-2 OS cells treated with selenium, 
there is no induction of phosphorylation at serine 2056 or threonine 2647 of DNA-
PKcs.  Also total levels of DNA-PKcs are the same in each treatment, with each cell 
expressing similarly high levels of DNA-PKcs. 
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3.3.3 U2- OS cells  
 
Figure 3.17 shRNA U-2 OS control cells treated with sodium selenite. A) After 
selenite treatment for 24 hours, the cells were probed for pDNA-PKcs S2056, pDNA-
PKcs T2647 and γH2A.X. The levels of phosphorylated H2A are less than U-2 OS 
cells with ATM knocked down. 
γH2A.X 
γH2A.X 




Figure 3.17 B) shRNA U-2 OS control cells treated with selenium then probed for 
pDNA-PKcs S2056, pDNA-PKcs T2647 and total DNA-PKcs.  The total levels of 
DNA-PKcs are similar throughout the experiments. 
     pS2056 
     pT2647 
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Figure 3.17 C) shRNA U-2 OS control cells treated with NCS then probed for 
pDNA-PKcs S2056, pDNA-PKcs T2647 and total DNA-PKcs.  With ATM present, 
there is an enhanced response to NCS treatment; illustrating the phosphorylation of 
DNA-PKcs at both foci following NCS response is dependent on proper function of 
ATM. 
     pS2056 
     pT2647 
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Similar to ATM shRNA U-2 OS cells, there is very little selenium-induced 
phosphorylation of DNA-PKcs at serine 2056 or threonine 2647.  γH2A.X signal is 
consistent with the pattern of ATM shRNA U-2 OS cells. Unlike the ATM shRNA U-
2 OS cells, the control U-2 OS cells treated with selenium show very faint selenium-
induced phosphorylation response; however this response is not significant or 
noticeable when compared to the normal MRC-5 cells.  With ATM intact in the U-2 
OS cells, there is a small dose dependent selenium-induced phosphorylation event at 
the two DNA-PKcs phosphorylation sites.   
The levels of total DNA-PKcs in the control cells are similar to the levels in 
the ATM shRNA cells, and are independent of selenium treatment. Total DNA-PKcs 
is the same in each treatment, regardless of NCS dose.  Unlike the U-2 OS cells with 
ATM expression knocked down, serine 2056 and threonine 2647 of DNA-PKcs in U-2 
OS control cells has a more robust phosphorylation response to a dose dependent 
NCS treatment.  Both cancer cell lines tolerate NCS treatment better than the normal 
MRC-5 cell line, and the U-2 OS control cells have phosphorylation of DNA-PKcs, 
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Chapter 4:  Discussion  
4.1 Conclusions 
 
 4.1.1 The protein components of the NHEJ pathway are necessary for a selenium-
induced DNA Damage Response  
 
 The NHEJ is the predominant pathway that repairs potentially oncogenic 
DNA DSBs, although it is error prone (Mao et al., 2008).  We showed here, through a 
knockout study, that competent Ku70, Ku80 and DNA-PKcs proteins are necessary in 
mouse embryonic fibroblasts in order to generate a selenium-induced ROS response.  
Therefore, the proposed role of ROS in mitigating tumorigensis might be dependent 
on a unique interaction with the protein components of the NHEJ pathway.  The 
ability to scavenge free radicals is thought to decrease risk of cancer by decreasing 
free radical damage to tissue.  However, here, we give support to an opposite 
hypothesis; the mild oxidative stress caused by selenium treatment preferentially 
activates DNA damage response and repair genes in normal cells, but not in cancer 
cells.  Since the protein components of the NHEJ pathway are necessary for 
selenium-induced ROS production, their modification could be a missing link in 
selenium chemoprevention.     
 
4.1.2 DNA-PKcs is phosphorylated at T2647 and S2056 in response to DNA Damage
  
  
 The ATM/ATR dependent phosphorylation site of DNA-PKcs, threonine 2647, 
and the autocatalytic phosphorylation site of DNA-PKcs, serine 2056, are both 
susceptible to selenium treatment.   Both sites are up-regulated in response to sodium 
selenite treatment; meaning these cells have higher activity of proteins that are 
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important in maintaining the integrity of their DNA.  An interesting analogy to 
consider is that the mild, tolerable oxidative stress generated by selenite is like lifting 
heavy weights.  The oxidative stress up-regulates the cell’s DNA damage response 
and the heavy lifting causing small tears in the muscle, both of which, when repaired 
are beneficial to the organism.  In the case of the cell, the DNA has increased 
protection and immediate repair, and in the case of the muscle it heals by laying down 
extra muscle fiber which ultimately increases the fitness of the individual. 
 
 4.1.3 DNA-PKcs phosphorylation is attenuated in the S-phase in MRC-5 cells 
  
 When normal MRC-5 cells are arrested in the S-phase using aphidicolin 
treatment, there is less phosphorylation of either residue of DNA-PKcs compared to 
when the cells are in a mixed population.  The other type of DNA DSB repair is 
homologous recombination which can take place when the cell has a homologous 
chromosome available as a template.  The homologous template, gotten from a sister 
chromatid, is only available after the cell has replicated (Reference Figure 4.1).  
Therefore, our results are congruent with other’s results that NHEJ is least active in 
S-phase, where primarily homologous recombination is used.  Homologous 
recombination is less error prone because the damaged DNA invades its sister 
chromatid at the site of the DSB and forms a holiday junction, ensuring the correct 
sequence is replicated.  This is in stark contrast to the NHEJ pathway because there is 
only minimal end-processing followed by a direct ligation of the DSB at the site of 
the lesion.  




Figure 4.1 The Cell Cycle The cell cycle is important when studying DNA damage 
response because the activation of some DNA damage repair proteins are specific to 
cell phase.  Selenium, the focus of this thesis work, has been shown to arrest cells in 
the G1 phase (Zeng et al., 2009), which is a proposed mechanism of how selenium 
could reduce tumor cell invasion in other tissues. Also, some following experiments 
use chemicals that can interfere with cell cycle progression, such as aphidicolin, 
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 4.1.4 DNA-PKcs phosphorylation decreases in response to ATM inhibition in MRC-5 
cells 
 
ATM enzymatic inhibition down regulated DNA-PKcs phosphorylation.  
Therefore, ATM activation and kinase activity is an upstream event and necessary for 
proper phosphorylation of DNA-PKcs at threonine 2647 and at serine 2056.  Even 
though serine 2056 is an autocatalytic site, where DNA-PKcs itself phosphorylates the 
site, it still must require proper upstream signaling from ATM.  When ATM is 
inhibited there is less phosphorylation than when ATM is not chemically inhibited.  
Furthermore, selenium is able to modify this phosphorylation event when ATM has 
kinase ability and when ATM does not have kinase ability.  When ATM is fully 
functioning as a kinase, the phosphorylation of both sites on DNA-PKcs is increased, 
while when ATM is enzymatically inhibited, the increase phosphorylation is not 
significant or consistent.   
4.1.5 DNA-PKcs inhibition increases T2647 phosphorylation and decreases S2056 
phosphorylation after selenium treatment 
 
 When normal MRC-5 cells are treated with NU 7026, a chemical DNA-PKcs 
inhibitor, the kinase ability of DNA-PKcs is comprised.  This is what we expected 
because the function of NU 7026 is to inhibit the kinase activity of DNA-PKcs and 
serine 2056 is an autocatalytic phosphorylation site.  Thus, DNA-PKcs still can be 
phosphorylated at other residues by other kinases, such as why we see an increase in 
phosphorylation of threonine 2647 on DNA-PKcs. T2647 is independent of DNA-
PKcs kinase activity and only needs proper function of ATM and/or ATR in order to 
be phosphorylated properly.  Also, these results show DNA-PKcs is downstream of 
ATM; with DNA-PKcs kinase ability reduced, ATM activity is similar to control 
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conditions, when no kinase inhibitors are used.  Therefore, DNA-PKcs activation is 
downstream of ATM activation in the DNA damage response induced by selenium. 
 
4.1.6 Selenium does not induce a DNA Damage Response in either cancer cell line 
 
Selenium can preferentially target normal cells because they might be more 
sensitive to lower doses of chemicals.  Therefore, in the case of the selenium, normal 
cells may have increased sensitivity to ROS signaling generated by supranutritional 
doses of selenium.  In the two cancer cell lines used in this experiment, neither cell 
line exhibited significant DNA-PKcs phosphorylation with any combination of 
chemicals (Figures 3.16 and 3.17).  It is possible that we were unable to target the 
specific pathway we were in normal cells because cancer cells are able to replicate 
when they have DNA damage.  Cancer cells can bypass checkpoints because of 
mutations in their DNA damage repair genes.  This conclusion would support our 
hypothesis because if selenium can target and up-regulate DNA damage repair it 
would be unable to do so in cancer cells harboring mutations in their DNA damage 
repair genes. 
  
4.2 Possible Weaknesses 
One potential weakness of this experiment would be the specificity of the 
enzymatic inhibitors.  Although these same inhibitors are used in high impact 
journals, their chemical structure and targets are somewhat analogous. Due to the 
similarity in structure and function of DNA-PKcs and ATM, it could be that our 
inhibitors have cross-effects.  There might be partial kinase inhibition of the kinase 
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the drug was not designed for; the chemical structure is similar, only differing by KU 
55933, the ATM inhibitor, having added sulfur groups.  A future experiment to 
confirm the efficacy of the inhibitors would involve a knock-down or a double 
negative. 
Another possible weakness of this study involves the dosages and types of 
selenium used in all experiments, and the limitations involved in doing in vitro tissue 
culture work.  Ideally, this study would test a greater variety of time points, types of 
selenium, doses of selenium, and methods of quantification.  Also, the conclusions 
drawn from this work are based solely on in vitro experiments; which, when studying 
human nutrition, is not ideal.  However, these experiments provide the first evidence 
of the cross-talk between two kinases of the PIKK protein family in the cellular 
response to selenium compounds.   
 
4.3 Perspectives  
Here we have identified a novel role of selenium as an inducer of the DNA-
PKcs pathway.  Selenite can induce a DNA damage response, which is a known 
tumorigenesis barrier (Bartkova, Horejsi et al. 2005),   in normal MRC-5 cells, but 
not in cancerous U-2 OS cells.  Specifically, selenium can induce phosphorylation of 
serine 2056 and threonine 2647 of DNA-Pkcs at sites of DNA breaks.  This is 
significant because activation of these sites is important for signaling pathways after 
formation of double-stranded DNA breaks in normal MRC-5 cells, but not in 
cancerous U-2 OS cells.  
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We put forward that the mechanism by which selenium enhances the DNA 
damage response in normal MRC-5 cells, but not in cancerous U-2 OS cells is a redox 
response, presumably by the internal generation of ROS by selenium’s innate 
metabolism at a supranutritional dose.  Selenium has been widely studied for its 
antioxidant function, as a scavenger of ROS at the nutritional dose, but here we 
illustrate selenium could act as a generator of ROS at a supranutritional dose.   This 
generation of ROS, we propose, is a signal for precancerous cells to enhance their 
DNA damage response, while cancer cells are immune to this signaling.  It would be 
interesting to further this experiment and elucidate why normal cells are affected by 
the selenium-induced mild oxidative stress, while cancer cells can escape the 
signaling pathways generated by the mild induction of oxidative stress.   
In conclusion, the results presented here show selenium may counter-act 
tumorigenesis through DNA damage response, specifically by a mechanism involving 
ATM-dependent DNA-PKcs phosphorylation. Taken together, our results provide the 
first evidence of ATM and DNA-PKcs cross-talk as an early tumorigenesis barrier in 
response to selenium exposure in noncancerous cells, and places ATM upstream of 












Appendix I: Chemicals and reagents 
10% SDS Teknova S0184 
10XTBS Bio-Rad 170-6435 
10XTBS Bio-Rad 170-6435 
Aphidicolin Calbiochem 178273 
DMEM,1X Cellgro 10-017-CV 
DMSO Sigma D5897 
Ethanol (absolute) Merck 100986 
Fetal Bovine Serum Atlanta S11550 
Glycine Sigma 
Hydroxyurea MP Biomedicals AAAL01120-03 
KU 55933 Tocris 
MEM Cellgro 
Methaneseleninic acid, 95%  Sigma 28274-57-9 
Methanol Fisher A452-4 
Non-Fat Dry Milk Bio-Rad 170-6404 
NP40 Calbiochem 492016 
NU 7026 Tocris 
Penicillin-Streptomycin Cellgro 30-002-CI 
Ros Dye Invitrogen 
Se-Methyl-selno-L-cysteine Sigma 26046-90-2 
Sodium selenite Sigma 10102-18-8 
Tris-HCl Quality Biological 351-007-101 
Trypsin EDTA, 1X Cellgro 25-052-C 














Appendix II: Buffer, solution and gel 
10X PBS 
80 g NaCl, 10 g KCl, 72 g Na2 hPO4, 12 g 
KH2PO4, 1 L dd H20 
Cell culture medium  
500 mL DMEM medium, 10% Fetal Bovine 
Serum for DMEM 15% Fetal Bovine Serum 
for MEM, 5 mL Penicillin-Streptomycin, 5 
mL Non essential amino acids, 5 mL 
essential amino acids, 5 mL MEM vitamins,  
TBS-T 
100 mL 10XTBS, 900 mL ddH20, 10 mL 
10% Tween20 
 
Appendix III: Commercial kits 
BCA
TM
 Protein Assay Kit Thermo JI124811 
Senescence Detection Kit Qiagen 301107 
 
Appendix IV: Equipments and facilities used 
Balance Denver Instrument S-403 
Biological Safety Cabinet Thermo 109578 
CO2 incubator Thermo 3595 
FLUOstar OPTIMA BMG 413-3128 
Isotemp Air Bath Fisher 11-715-1250 
Isotemp Water Bath Fisher 15-462-01 
Legen RT centrifuge Thermo 75004377 
Optic Microscope Motic AE21 
Rocker VWR 12620-906 
Roto-Shake Genie Scientific Industries S1-1100 
Vortex-Genie Scientific Industries 2-401968 
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